Search Results 1601-1610 of 24337 for Periods
... period and a long-term GS-4997 treatment period. Participants completing the 24-week placebo-controlled period will be eligible to receive active treatment ...
There are 3 arms in this study to which patients will be randomized in a ratio of 1:1:1 to receive the DA-1229 or placebo orally once daily for a period of 104 ...
... Period of the study. Subject agrees to maintain current preventive headache medication regimens (no change in type, frequency, or dose) - except to manage ...
Diseases that affect the peripheral nerves, such as diabetes, also can cause numbness. But diabetes usually causes numbness in the feet first.
Vancomycin, when taken by mouth, is used to treat Clostridioides difficile-associated diarrhea (also called C diff). C diff is a type of bacteria that causes ...
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...
The study is divided into a Screening Period, a Treatment Period (consisting of a Primary Phase, a Day 169 Disease Response Assessment, and an Extension ...
Electrocardiogram (ECG or EKG). This is the most common test to diagnose tachycardia. · Holter monitor. If a standard ECG doesn't give enough details, your care ...
Rochester, Minn. The purpose of this study is to evaluate the effectiveness, safety, tolerability, and PK of INCB000928 over a 24-week treatment period followed ...
... period of 48 weeks. All patients will be eligible to continue in an open-label extension trial of L-CsA following completion of BOSTON-2. BT – L-CsA – 301 ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.